Petrography of Yamato 984028 lherzolitic shergottite and its melt vein: Implications for its shock metamorphism and origin of the vein

AbstractYamato 984028 (Y984028) is a newly identified lherzolitic shergottite, recovered from the Yamato Mountains, Antarctica, in 1999. As part of a consortium study, we conducted petrographic observations of Y984028 and its melt vein in order to investigate its shock metamorphism. The rock displays the typical non-poikilitic texture of lherzolitic shergottite, characterized by a framework of olivine, minor pyroxene (pigeonite and augite), and interstitial maskelynite. Shock metamorphic features include irregular fractures in olivine and pyroxene, shock-induced twin-lamellae in pyroxene, and the complete conversion of plagioclase to maskelynite, features consistent with those found in other lherzolitic shergottites. The melt vein is composed of coarse mineral fragments (mainly olivine) entrained in a matrix of fine-grained euhedral olivine (with several modes of compositional zoning) and interstitial glassy material. Some coarse olivine fragments consist of an assemblage of fine-grained euhedral to subhedral olivine crystals, suggesting shock-induced fragmentation, recrystallization, and/or a process of sintering. The implication is that the fine-grained olivine crystals in the matrix of the melt vein represent complicated crystallization environments and histories

A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia

Leukocytes that lack HLA allelic expression are frequently detected in patients with acquired aplastic anemia (AA) who respond to immunosuppressive therapy (IST), although the exact mechanisms underlying the HLA loss and HLA allele repertoire likely to acquire loss-of-function mutations are unknown. We identified a common nonsense mutation at position 19 (c.19C>T, p.R7X) in exon 1 (Exon1mut) of different HLA-A and -B alleles in HLA-lacking granulocytes from AA patients. A droplet digital PCR (ddPCR) assay capable of detecting as few as 0.07% Exon1mut HLA alleles in total DNA revealed the mutation was present in 29% (101/353) of AA patients, with a median allele frequency of 0.42% (range, 0.071% to 21.3%). Exon1mut occurred in only 12 different HLA-A (n=4) and HLA-B (n=8) alleles, including B*40:02 (n=31) and A*02:06 (n=15), which correspond to 4 HLA supertypes (A02, A03, B07, and B44). The percentages of patients who possessed at least one of these 12 HLA alleles were significantly higher in the 353 AA patients (92%,